Craniotomy is a surgical procedure that involves opening the skull to gain access to the brain. It is used to treat a variety of conditions, including brain tumors, aneurysms, and hydrocephalus. It is a complex and delicate procedure, and requires a great deal of skill and precision from the medical team. In recent years, there have been significant advances in the field of craniotomy that have revolutionized the way this procedure is performed. This article will explore these advances and discuss how they have changed the way brain surgery is performed.
Craniotomy has been performed for centuries, but the procedure has changed significantly over time. In the past, craniotomies involved large incisions and a great deal of tissue trauma. This often led to significant complications, such as infections and bleeding. As medical technology advanced, surgeons began to use smaller incisions and more precise instruments, which led to fewer complications and better outcomes.
In recent years, there have been significant advances in the field of craniotomy that have revolutionized the way this procedure is performed. The most significant of these advances is the development of minimally invasive craniotomy (MIC). This technique involves using small incisions, specialized instruments, and imaging technology to gain access to the brain. This technique reduces the amount of tissue trauma, which leads to fewer complications and better outcomes.
Robotic craniotomy is another recent advancement in the field of craniotomy. This technique involves the use of a robotic arm, which is controlled by the surgeon. The robotic arm is able to make precise incisions and movements, which reduces the amount of tissue trauma and leads to fewer complications. In addition, the robotic arm can be programmed to follow a predetermined path, which can help reduce the amount of time the procedure takes.
Computer assisted craniotomy is a relatively new technique that is becoming increasingly popular. This technique involves the use of a computer to create a 3D model of the patient’s brain. This model can be used to plan the procedure, which can help reduce the amount of time it takes to complete the procedure. In addition, the model can help the surgeon to identify potential risks and plan the best approach to the procedure.
Craniotomy is a complex and delicate procedure, and requires a great deal of skill and precision from the medical team. In recent years, there have been significant advances in the field of craniotomy that have revolutionized the way this procedure is performed. These advances include minimally invasive craniotomy, robotic craniotomy, and computer assisted craniotomy. These techniques have led to fewer complications and better outcomes, and have ushered in a new era in brain surgery.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation